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There are no current descriptions of general anaesthesia characteristics for obstetric surgery, 
despite recent changes to patient demographics and airway management guidelines. This analysis of 
data from the Direct REporting of Awareness in MaternitY patients (DREAMY) study of accidental 
awareness during obstetric anaesthesia aims to describe practice for obstetric general anaesthesia in 
England and compare with prior surveys and best practice recommendations. From May 2017 to 
August 2018 consenting patients receiving general anaesthesia for obstetric surgery in 72 hospitals 
were included. Patient demographics, airway management, anaesthetic techniques and major 
complications data were collected. Descriptive analysis, binary logistic regression modelling and 
comparisons with prior data were conducted. Data were collected from 3117 procedures, including 
2554 (81.9%) caesarean deliveries. Thiopental was the induction drug in 1649 (52.9%) participants, 
compared to propofol in 1419 (45.5%). Suxamethonium was the neuromuscular blocking drug for 
tracheal intubation in 2631 (86.1%), compared with rocuronium in 367 (11.8%). Difficult intubations 
occurred in 1 in 18 (95% CI: 1 in 16–21); failed intubation occurred in 1 in 309 (95% CI: 1 in 170–625). 
Videolaryngoscopy was used rarely (1.9%). Obese patients were over-represented compared to 
national baselines and associated with difficult, but not failed intubation. Use of general anaesthesia 
induction drug (increased propofol) has changed far more than use of neuromuscular blocking drugs 
(suxamethonium remains most popular). Although suboptimal, there is evidence of improvement in 
practice with increased monitoring and reversal of neuromuscular blockade. Despite a high risk of 






Neuraxial anaesthesia is the preferred technique for most obstetric operative procedures [1]. 
However, general anaesthesia (GA) is still required in some clinical situations. The provision of GA in 
obstetric patients remains a cause for concern and debate regarding best practice, with concerns 
including an increased risk of failed intubation and accidental awareness during general anaesthesia 
(AAGA) and the impact on maternal experience [2-4].  
The 5th National Audit Project (NAP5) of the Royal College of Anaesthetists and the Association of 
Anaesthetists of Great Britain and Ireland into accidental awareness during general anaesthesia 
investigated accidental awareness under general anaesthesia. Both the primary investigation and 
the activity survey highlighted some of the unique challenges associated with general anaesthesia in 
obstetrics and also some of the idiosyncrasies of practice in this area, compared to the provision of 
general anaesthesia outside obstetrics [1,3]. 
The Direct REporting of Awareness in MaternitY patients (DREAMY study) was a multi-centre, 
prospective cohort study that aimed to establish the incidence, risk factors and sequelae of 
AAGA in obstetrics [5]. A secondary study was embedded within DREAMY with the aim to describe 
general anaesthetic practice in obstetric patients in the UK. Specifically, this study aimed to examine 
choice of drugs and airway management techniques and evaluate any change in practice since 
NAP5[1].  
Methods 
This investigation was planned a priori as a descriptive cross-sectional study of general anaesthesia 
characteristics for patients recruited to the Direct REporting of Awareness in MaternitY patients 
study. Research Ethics Committee (17/LO/0071) and Health Research Authority approvals were 
granted, alongside prospective registration of the primary trial aims (ClinicalTrials.gov Identifier: 
NCT03100396). Full details of the Direct REporting of Awareness in MaternitY patients study 
protocol are available separately [5]. This manuscript is reported in accordance with the STROBE 
statement for reporting observational studies [6].  
Recruitment occurred in NHS hospitals in England between May 2017 and August 2018. Data were 
collected on patients undergoing GA for obstetric surgery provided the following inclusion criteria 
were met: age ≥18 years, surgery with an obstetric indication occurring at ≥ 24/40 weeks of 
gestation to <48 hours postpartum and written consent. Pregnant patients receiving GA for a non-
obstetric indication (e.g. colorectal surgery) were excluded, as were patients who were too unwell to 
participate in the AAGA interview components of the primary study and those unable to 
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communicate in English. The study was supported by an affiliated anaesthetic trainee network, the 
Pan-London Perioperative Audit and Research Network (PLAN). Collaborations with anaesthetic 
trainee networks outside London were invited. 
Aspects of general anaesthetic conduct that were evaluated, included indications for GA, the 
training grade of the most senior anaesthetist present, time and duration of GA and anaesthetic 
induction technique (use of rapid sequence induction; RSI). Anaesthetic pharmacological data 
included choice and dose of induction agent, maintenance agent, neuromuscular blocking drug 
(NMBD) and use of neuromuscular blocking reversal agent. 
Data on airway management included direct laryngoscopic view, based upon a modified version of 
the original Cormack and Lehane grading [7,8]. The primary airway device used, difficulties with 
airway management and intubation technique (including videolaryngoscopy or awake tracheal 
intubation) were recorded. Data were collected on critical incidents including regurgitation, 
aspiration and critical care admission. 
Difficult intubation was defined as a clinical situation in which the most senior anaesthetist present 
required multiple (≥2) attempts or was unable to successfully intubate the trachea, or based on the 
subjective opinion of the anaesthetist as recorded on the anaesthetic chart. 
Demographic data included: age of patient, parity, American Society of Anesthesiologists (ASA) 
physical status score, booking weight, height and body mass index. The surgical procedure was 
recorded, as either caesarean section (CS), exploration under anaesthesia (EUA), manual removal of 
placenta (MROP) or specified individually according to the procedure undertaken. Urgency of CS was 
classified in accordance with the model proposed by Lucas et al [9] and adopted by the Royal College 
of Obstetricians and Gynaecologist in the United Kingdom using Categories 1 to 4; Category 1 
representing surgery needed due to immediate threat to life of the mother or baby, to Category 4 
being performed electively. The urgency of non-CS procedures was classified using the NCEPOD 
model (immediate, urgent, expedited, elective) [10]. Results were presented separately for CS and 
non-CS procedures, for ease of comparison with previous and future surveys of obstetric practice. 
All data was collected via an online secure database (developed using REDCap) [11]. The sample size 
was determined by the primary outcome in the Direct REporting of Awareness in MaternitY 
patients study. Descriptive statistics were calculated for patient and procedure variables. Frequency 
and percentage were presented for each categorical variable. For skewed continuous variables, the 
median and interquartile range (IQR) were calculated along with the range. Proportion of difficult 
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and failed intubations were calculated with 95% confidence intervals (CI). Missing data was declared 
for each outcome. 
Continuous variables were compared using independent t-test or Wilcoxon rank-sum test, as 
determined by assessing normality of sample data distribution with Shapiro-Wilk testing. Categorical 
variables were analysed using chi-squared or Fisher’s exact test. Binary logistic regression analysis 
was performed to identify independent factors influencing induction hypnotic drug choice and 
airway complications. All significant covariates after univariate testing were entered into a 
multivariable logistic regression analysis. Hospitals were grouped and analysed according to Health 
Education England anaesthetic training regions, which were expected to provide a balance between 
geographic distribution and relative homogeny of practice. Odds ratio (OR) with 95% confidence 
intervals were used to quantify effect sizes. Significance was estimated with the Wald test. All 






A total 3115 patients providing written informed consent for inclusion following eligibility screening 
of 4969 patients. Participation included 72 (45.6%) of the 158 National Health Service hospitals 
where obstetric anaesthesia services are offered in England, although patient recruitment was 
weighted towards London and Southern England (Figure 1; Table S1). Hospitals included a mixture of 
teaching (22 hospitals) and district general hospitals (50 hospitals); although all hospitals were 
similar in providing labour ward and obstetric operating theatre facilities. The median (IQR [range]) 
number of patients recruited at each site was 37 (25-59 [3-146]). Four patients underwent two 
recorded GAs during their inpatient stay, with both anaesthetic episodes included, and two patients 
had no anaesthetic data reported; hence the total number of GA episodes for data analysis was 3117 
(Figure 1). 
Patients and operations 
Baseline characteristics of included patients are provided in Table 1. Demographic data for patients 
who received GA for obstetric surgery were different from national baseline maternity patient 
statistics [12,13]. Patients receiving GA were slightly older (mean difference = 1.0 year (95% CI: 0.79 
– 1.20); p < 0.01) and more likely to be primigravid (difference = 18.3% (95% CI: 15.7% – 19.1%); p < 
0.01). Women with BMI ≥ 30kg.m-2 were marginally over-represented (difference = 3.1% (95% CI: 
1.6% – 4.6%); p < 0.01) (Table 1). 
A total of 2554 GAs (81.9%) were undertaken for CS, of which 1329 (42.6%) were classed as Category 
1. Most GAs were initiated de novo, before initial surgical incision; although a minority were 
conversion to GA after surgery had started, typically due to inadequate neuraxial block (Table 2). The 
median (IQR [range]) duration of surgery was 60 (45-75 [6-390]) minutes. 
Drugs and induction technique 
Rapid sequence induction (RSI) was the preferred anaesthetic induction technique for the almost all 
patients, being used in 3099 (99.4%) participants. Thiopental was the most commonly used hypnotic 
drug for induction of GA, being used in 1649 (52.9%) (Table 3). Propofol was used for induction in 
1419 (45.5%) of patients and ketamine in 28 (0.9%). Two patients received etomidate as their 
primary induction hypnotic drug. One patient received thiopental followed by additional boluses of 
propofol during induction of GA. One patient with severe needle phobia underwent an inhalational 
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induction with sevoflurane and cricoid pressure, followed by attainment of intravenous access and 
additional intravenous hypnotic drugs. In the majority of participants maintenance of GA was with 
volatile agents (Table 3 and Figure 2). 
Non-CS surgery was more likely to be associated with propofol induction (OR 1.90; 95% confidence 
interval 1.51-2.39). All types of less urgent surgery were associated with greater propofol rather 
than thiopental use. The OR for propofol use for was 1.19 (95% CI: 1.10-1.29) as the urgency of 
surgery declined from “immediate” to “elective”. Higher categories of ASA physical status score 
were also associated with a higher OR of propofol use; 1.18 (95% CI: 1.03-1.35). The geographic 
region in which hospitals were located was also associated with variable ORs for propofol usage 
(Figure 3 and Table S2). 
Short-acting opioids during induction of GA were given to 1351 (44.2%) of participants, of which 
fentanyl was the most popular choice (Table 3 and Figure 2). For CS surgery, short-acting opioid use 
was lower than for non-CS obstetric surgery (p <0.0001). 
Suxamethonium was used more frequently than rocuronium (Table 3) as the NMBD for tracheal 
intubation (84.5 vs. 11.4%). Of the 1620 participants that received non-depolarising NMBDs, 1427 
(88.1%) received a neuromuscular blocker reversal drug. For the majority of participants, 1184 
(83.0%), the drug combination used was neostigmine with glycopyrrolate. Sugammadex reversal was 
used in the 219 of the 533 participants (41.1%) who received rocuronium. Nerve stimulator 
monitoring of neuromuscular blockade was documented for 855 (52.8%) patients receiving non-
depolarising NMBD. 
Processed electroencephalogram (pEEG) depth of anaesthesia monitoring was applied to 148 (4.7%) 
patients across only seven hospital sites. No other form of depth of anaesthesia monitoring was 
recorded. 
Airway management 
Tracheal intubation was the airway management method for 3099 (99.4%) participants. The 
remaining 18 participants (0.6%) underwent surgery using a supraglottic airway device. A first 
generation device was used in three participants and second generation supraglottic airway device 
in 15 participants [14]. Of these 18 patients, eight (44.4%) received the supraglottic airway following 
failed attempts at tracheal intubation. The remaining non-rescue supraglottic airways were used 
predominantly in non-emergency, non-CS surgery (including insertion of cervical cerclage and 
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MROP). No participants required emergency front of neck access surgery for a “can’t intubate, can’t 
oxygenate” scenario; no cricothyrotomies were performed. There were two complications of 
suspected gastric aspiration during airway management. 
Grade 3-4 laryngoscopy occurred in 1:38 of all GAs (95% CI: 1 in 31 – 47). A small proportion (1.4%) 
of airways with a grade 1 view at direct laryngoscopy were subjectively reported as difficult. These 
difficult intubations were associated with vocal cord oedema in the context of pre-eclampsia or 
technical problems (including endotracheal tube cuff leakage or difficult bag-valve mask ventilation). 
Difficult intubations for all types of obstetric surgery were reported in 1 in 18 (95% CI: 1 in 16 – 21) 
of all GAs. For patients with reported difficult tracheal intubation, a bougie was used successfully in 
103 (66.9%). Videolaryngoscopy was used rarely, in only 59 (1.9%) participants. Failed intubation 
occurred in 10 participants (0.32%) or 1 in 309 (95% CI 1:170 – 625). General anaesthesia was 
continued for nine of these participants, undergoing surgery with a supraglottic airway device. One 
participant received GA following unsuccessful attempts at neuraxial anaesthesia; the trachea could 
not be intubated, the patient was safely woken and a neuraxial block was subsequently successfully 
sited. 
The prevalence of reported difficult intubation for CS surgery was 1 in 18  (95% CI: 1 in 15 – 21) and 
1 in 20 (1 in 14 – 31) for non-CS surgery. The prevalence of failed intubation was 1 in 345 (95% CI: 1 
in 169 – 909) for CS surgery and 1 in 179 (95% CI: 1 in 61 – 833) for non-CS surgery. 
Two participants underwent planned awake tracheal intubation for known difficult airways using 
flexible bronchoscopy prior to Category 3 and 4 CS surgery. Neuraxial anaesthesia was 
contraindicated in both participants, who received remifentanil target-controlled infusions for 
sedation during airway management. Neither participants suffered any reported complications. 
On regression analysis, the OR of encountering a Grade 3-4 laryngoscopy was not significantly 
related to weight (p = 0.41), BMI (p = 0.87), age (p = 0.13), grade of anaesthetist (p = 0.74), surgical 
procedure (p = 0.58), choice of induction hypnotic drug (p = 0.29), choice of NMBD (p = 0.22), 
urgency of surgery (p = 0.51) or whether GA was commenced prior to the initial surgical incision or 
during surgery, as a conversion from regional anaesthesia (p = 0.66). Raised BMI was not associated 




Ten participants (0.3%) had Grade 4 direct laryngoscopy views, two of which resulted in a failed 
intubation and subsequent rescue with a supraglottic airway devices. Videolaryngoscopy was not 
used for either participant. The trachea was intubated using a bougie in two participants and via 
videolaryngoscopy in six participants. 
Staffing and workforce considerations 
Over half of GAs, 1732 participants (55.6%), were started during day shift hours (08:00 to 20:00). 
With only 446 procedure (14.3%), the least common period of time for GAs to start was 04:00 to 
08:00. Weekend days had a mean difference of 27.4% (95% CI: 26.5% – 28.3%) fewer GAs than 
weekdays. 
Staffing for GAs differed significantly depending upon the GA start time, with consultant presence 
falling from 1067 (64.1%) during the day shift, to 145 (11.0%) overnight. Difficult intubations were 
not significantly over-reported during day shift hours, compared with overnight: 98 (5.7%) vs. 66  
(4.8%; p = 0.26). Nor was Grade 3-4 laryngoscopy was over-reported during the day shift: 50 (3.9%) 





The main finding of this study is about the use of anaesthetic agents; that the traditional 
pharmacological paradigm of thiopental and suxamethonium for RSI in obstetrics that has been 
maintained in the UK, is being increasingly substituted with propofol and, to a lesser extent, 
rocuronium. In 2013, a UK survey of consultant obstetric anaesthetists identified that thiopental was 
routinely used by 93% of respondents for induction of general anaesthesia for caesarean section 
[15]. In 2013 NAP5 found that 97% of obstetric GA inductions used thiopental. Our finding, that 
thiopental was used in just over half of participants, with propofol used in most of the others, 
represents a significant change in practice. Propofol use was associated with procedures other than 
CS, less urgent surgery, and patients with more comorbidities. However, the use of thiopental 
remains extremely high compared with its use within the non-obstetric surgical population [1]. 
The relative persistence of thiopental as the induction agent of choice in obstetrics was attributed to 
two main reasons; a belief that the use of thiopental was associated with a reduced risk of AAGA, 
and improved neonatal outcomes compared with other agents [15]. The evidence supporting these 
perceptions is, at best, limited with almost no adequately powered, large scale investigations [16]. 
Outside of the UK, there has already been a shift towards propofol as the induction agent of choice 
for CS under GA, most likely as a result of limited access to thiopental, as opposed to clear evidence 
of benefit with propofol. The debate around this subject in the UK was re-ignited by the publication 
of NAP5 and the UK Maternal Confidential Death Enquiries report (MBRRACE-UK) [17] by Knight et 
al. NAP5 reported that AAGA appeared significantly over-represented in patients who received 
anaesthetic induction with thiopental. Knight at al found that in some maternal deaths, the dose of 
thiopental (and much less often, propofol) used for induction of anaesthesia in severely ill women 
appeared excessive. These results support the assertion that UK anaesthetists are increasingly 
unfamiliar with thiopental and its continued use in obstetric practice may be causing harm. 
However, this should be considered alongside the impact of a dramatic reduction in the number of 
women who receive GA for CS [18]. It is too soon to say whether the problems highlighted by NAP5 
and Knight et al are related to reduced familiarity with thiopental per se or reduced familiarity with 
GA in obstetric practice generally. 
The use of short-acting opioids during induction of anaesthesia has increased, with 43.2% of patients 
in our study receiving either fentanyl, alfentanil or remifentanil at induction. NAP5 reported opioid 
use in only 23.4% of obstetric GAs in 2013. Opioids have traditionally been avoided as part of RSI for 
CS because of concerns about the potential adverse effect on the neonate, and also in the event of 
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failed intubation and discontinuation of anaesthesia, that they may delay the return of spontaneous 
ventilation in the mother. There is a paucity of data to support either of these assertions. Opioids 
are effective sympatholytic agents; additionally they can reduce the “induction agent – maintenance 
inhalational gap”, which has been identified as a specific problem in GA for CS, because surgery 
starts so soon after induction, potentially increasing the risk of AAGA. Previous surveys have 
identified a disparity between opioid use in obstetric versus non-obstetric RSI, with greater use 
outside the obstetric setting [19]. A recent meta-analysis has shown that induction opioids 
(remifentanil and alfentanil, in particular) appear to be safe, with no significant effect on Apgar 
scores or neonatal airway intervention [20]. Research is needed to define the ideal dose and timing 
of opioids during GA for CS. 
Our data suggest a decline in the predominance of suxamethonium in obstetric GA. In both the 
NAP5 (2013) and 6th National Audit Project (NAP6) activity surveys (2016), suxamethonium was used 
for tracheal intubation in more than 90% of obstetric patients [1,21]. In this study, it was used for 
only 86% of participants, even though almost all used RSI. There are indications of improvements in 
practice around the use of NMBDs since NAP5. In our study, reversal of neuromuscular blockade was 
used for 88.1% of patients who received a non-depolarising drug, an increase from 68% reversal 
usage identified in NAP5, but still leaving 11.9% of patients at unnecessarily increased risk of AAGA 
through residual blockade on emergence. Both NAP5 and the AAGBI guidelines for standards of 
monitoring during anaesthesia and recovery recommend using quantitative peripheral nerve 
stimulation monitoring to reduce this risk [22]. Just over half of the patients in this study who 
received NMBDs were monitored with a nerve stimulator, compared with only 38% in overall 
surgical patients in 2013 and 37% in 2016 [1,21]. Although suboptimal practice remains a concern, 
reversal and monitoring of neuromuscular blockade are more consistent with best practice 
guidelines in obstetric anaesthesia than for overall surgery in the UK. The role of rocuronium in 
obstetric anaesthetic practice has yet to be clearly defined, which perhaps explains the change in 
practice in one area of obstetric GA (induction agent) but not another (NMBD) [23]. 
A striking finding of our study was a very high incidence of difficult intubation at 1 in 18 (95% CI: 1 in 
16 – 21). This is higher than previously reported by a prospective study of 1095 obstetric participants 
in Australia and New Zealand, which reported an incidence of 1 in 30 (95% CI: 1 in 22 – 43) [24]. 
Obesity was high in patients receiving GA relative to national maternity statistics and is a risk factor 
for difficult intubation. We found an incidence of failed intubation of 1 in 309, similar to the 
incidence identified in a prospective study in the UK of 1 in 224 (95% CI: 1 in 179 – 281) [4] and a 
meta-analysis collating data from international studies, which reported an incidence of 1 in 390 [25]. 
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Reassuringly we found minimal adverse events as a result of this. In 2011 the 4th National Audit 
Report of the Royal College of Anaesthetists (NAP4) received just four reports of adverse airway 
events in obstetrics [26]. They extrapolated an incidence of severe airway problems of 1 in 4,348 
(95% CI: 1 in 1,700 – 1 in 16,000). 
The data in our study represent the largest set of prospectively collected obstetric airway 
management data ever reported in the UK. If our estimate of difficult airway incidence of 1 in 18 is 
correct, the virtual absence of use of videolaryngoscopy is a concern. There is mounting evidence on 
the benefits of videolaryngoscopy for obstetric airway management [27,28]. In our study, 
videolaryngoscopes rescued 6 of the 6 patients in whom Grade 4 direct layngoscopic views were 
obtained and videolaryngoscopy techniques were attempted. A UK national survey found that in 
contrast to main theatres, the availability of videolaryngoscopes in obstetric units was more limited 
(91% compared to 55%) and this must be an urgent priority for obstetric anaesthetists [29]. We did 
not assess the use of high flow nasal oxygenation (HFNO) in obstetrics.  Although there is mixed 
evidence about the role of HFNO in obstetrics, it would be interesting to assess if this technique has 
permeated into obstetric practice [30,31]. 
The primary strength of this study is that it is one of the largest, prospective studies of obstetric 
general anaesthesia ever conducted and represents a valuable insight into current UK obstetric 
practice. However, this secondary study was limited by a requirement for consent in the primary 
study (Figure 1). This led to a higher proportion of women declining to participate, with only data 
from patients who specifically consented to the AAGA investigation aspect of the study included 
within this secondary analysis. Had we confined this to an observational study of practice, no 
consent would have been necessary, and we could have legitimately included greater numbers of 
participant data. 
Conclusion 
The conduct of general anaesthesia in obstetrics in England has changed since 2013. This is 
particularly true of the pharmacological preferences for induction of anaesthesia and neuromuscular 
blockade. Longer-acting NMBDs were used more often for tracheal intubation in our study than in 
the NAP5 activity survey. There was also increased use of neuromuscular reversal drugs and 
monitoring of NMBDs, both critical to minimise the risk of residual blockade and AAGA; however, 
current practice still falls short of the universal use advised by recent guidelines. Difficult intubation 
was common and the adoption of more advanced airway techniques such as videolaryngoscopy – 
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even perhaps to the point that this becomes the first-line technique for all –  may further improve 
safety. 
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Age (years) 31.5 (6.1) 30.5 (5.5) ONS*; 2017; 
England and 
Wales; n = 
679,106 
Weight (kg) 70 (60.8 – 84 [38 – 
188]) 
N/A ONS*; 2017; 




     <18.5 
     ≥18.5 <25 
     ≥25 <30 
     ≥30 
     ≥35 


















England; n = 
398,026 
Parity 
     1 
     2 
     3 
     ≥ 4 














England; n = 
398,026 
 
ASA PS score 
     1 
     2 
     3 
     ≥ 4 








Table 1. Baseline characteristics of included patients, all of whom received general anaesthesia for 
obstetric surgery. Results are presented as mean (SD), median (IQR [range]) and percentage values, 
as appropriate. Weights were recorded at time of pregnancy booking appointment. ASA PS = 
American Society of Anesthesiologists Physical Status score; healthy pregnant women were defined 
as ASA PS 1 for the purposes of this study. *Data source is Office for National Statistics 2017: 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/dat








CS surgery (n 
= 2554) 
Non-CS 





Emergency / Category 1 1329 (52.0%) 307 (54.5%) 1636 (52.5%) 
Urgent / Category 2 676 (26.5%) 139 (24.7%) 815 (26.1%) 
Expedited / Category 3 159 (6.2%) 19 (0.6%) 178 (5.7%) 
Elective / Category 4 375 (14.7%) 12 (3.3%) 387 (12.4%) 






De novo 1708 (66.9%) 494 (87.7%) 2202 (70.6%) 
Conversion from neuraxial 
anaesthesia to GA after initial 
surgical incision 
809 (31.6%) 52 (9.2%) 861 (27.6%) 
Unknown 37 (1.4%) 17 (3.0%) 54 (1.7%) 
Indication Clinical urgency (e.g. threat to 
life of mother or neonate) 
1279 (50.1%) 345 (61.3%) 1624 (52.1%) 
Maternal preference (e.g. 
anxiety) 
242 (9.5%) 66 (11.7%) 308 (9.9%) 
Neuraxial block contraindicated 
(e.g. thrombocytopenia, sepsis) 
333 (13.0%) 130 (23.1%) 463 (14.9%) 
Failed neuraxial block (e.g. 
unable to site neuraxial block, 
inadequate or early receding 
sensory block height) 
751 (29.4%) 51 (9.1%) 802 (25.7%) 
High neuraxial block (e.g. total 
spinal or patient distress from 
high block) 
18 (0.7%) 4 (0.7%) 22 (0.7%) 
Other (e.g. prolonged surgery, 
indicated for surgical 
procedure) 
86 (3.4%) 39 (6.9%) 125 (4.0%) 
Unknown 27 (1.1%) 10 (1.8%) 37 (1.2%) 
Table 2. Urgency and indication for general anaesthesia and surgery for obstetric patients. Multiple 
indication for GA were permissible, hence the total exceeds the number of participants. 







Characteristic CS surgery (n = 
2554) 
Non-CS surgery 
(n = 563) 
Total (n=3117) 
Induction hypnotic drug 
 
 
Thiopental 1431 (56.0%) 218 (38.7%) 1649 (52.9%) 
Propofol 1093 (42.8%) 326 (57.9%) 1419 (45.5%) 
Ketamine 9 (0.4%) 19 (3.4%) 28 (0.9%) 
Unknown 18 (0.7%) 0 (0%) 18 (0.6%) 
Neuromuscular blocking 
drug for tracheal 
intubation 
 
Suxamethonium 2158 (84.5%) 473 (84.0%) 2631 (84.4%) 
Rocuronium 292 (11.4%) 75 (13.3%) 367 (11.8%) 
Atracurium 50 (2.0%) 9 (1.6%) 59 (1.9%) 
Unknown 54 (2.1%) 6 (1.1%) 60 (1.9%) 
Opioid use during GA 
induction 
None 1623 (63.5%) 143 (25.4%) 1766 (56.7%) 
Fentanyl 487 (19.1%) 314 (55.8%) 801 (25.7%) 
Alfentanil 411 (16.1%) 103 (18.3%) 514 (16.5%) 




Sevoflurane 2141 (83.8%) 457 (81.2%) 2598 (83.3%) 
Isoflurane 251 (9.8%) 54 (9.6%) 305 (9.8%) 




18 (0.7%) 5 (0.9%) 23 (0.7%) 
Unknown 63 (2.5%) 30 (5.3%) 90 (2.9%) 
Nitrous oxide use during 
GA maintenance 
Nitrous oxide 1259 (49.3%) 267 (47.4%) 1526 (49.0%) 
Post-operative 
destination 
Delivery suite or 
post-natal ward 
(level 0) 
1722 (67.4%) 256 (45.4%) 1978 (63.5%) 
Obstetric high 
dependency 
care unit (level 
1-2) 
756 (29.6%) 264 (46.9%) 1020 (32.7%) 
General 
intensive care 
unit (level 2-3) 
44 (1.7%) 26 (4.6%) 70 (2.2%) 
Unknown 32 (1.3%) 17 (3.0%) 49 (1.6%) 
Time of GA induction 2000 – 07:59 
(i.e. night shift) 
1117 (43.7%) 266 (47.3%) 1383 (44.4%) 
Table 3. Summary of selected general anaesthetic (GA) and surgical characteristics for all obstetric 




Grade of direct 
laryngoscopy 
All (n = 3117) Difficult intubation (n 
= 155) 
Failed intubation (n = 
10) 
1 2355 (75.6%) 34 (21.9%) 0 (0%) 
2a 382 (12.3%) 29 (18.7%) 0 (0%) 
2b 147 (4.7%) 38 (24.5%) 4 (40.0% 
3 68 (2.2%) 45 (29.0%) 2 (20.0%) 
4 10 (0.3%) 8 (5.2%) 2 (20.0%) 
Unknown 155 (5.0%) 1* (0.6%) 2* (20.0%) 
Table 4. Modified Cormack and Lehane laryngoscopic view obtained by direct laryngoscopy and 




Legends to figures 
 
Figure 1. STROBE flowchart of participant recruitment. 
Figure 2. Summary of selected general anaesthetic characteristics. Data are total number of 
participants. 
Figure 3. Geographic distribution of induction hypnotic drug use for general anaesthesia according to 
Health Education England anaesthetic training regions in (A) England and (B) Greater London. Size of 
each plot represents the proportional number of participants originating within the corresponding 
region. Since Greater London represented 39.8% of all participating hospitals and 41.9% of all 
participants the region has been plotted separately. 
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